BriaCell Therapeutics Corp. (BCTX) Financials

BCTX Assets vs Liabilities
DateAssetsLiabilities
Jan. 31, 2024 12.2 million 20.5 million
Oct. 31, 2023 18.6 million 16.1 million
July 31, 2023 27.2 million 30.9 million
April 30, 2023 29.7 million 35.6 million

BCTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Jan. 31, 2024 -7.4 million 500155
Oct. 31, 2023 -7.6 million 533816
July 31, 2023 -10.9 million 533816
April 30, 2023 -5.3 million 281189

BCTX Net Income

No data available :(

BCTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Jan. 31, 2024 6.2 million - -
Oct. 31, 2023 13.6 million - -
July 31, 2023 21.3 million - -
April 30, 2023 28.2 million - -

BCTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Jan. 31, 2024 16.0 million
Oct. 31, 2023 16.7 million
July 31, 2023 16.0 million
April 30, 2023 15.5 million

BCTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Jan. 31, 2024 - 8.3 million 1.6 million -
Oct. 31, 2023 - 6.9 million 1.6 million -
July 31, 2023 - 5.2 million 2.5 million -
April 30, 2023 - 3.9 million 1.8 million -

BCTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Jan. 31, 2024 - -
Oct. 31, 2023 - 3735
July 31, 2023 - 3861
April 30, 2023 - 3816

BCTX

Price: $2.90

52 week price:
2.74
36.00

Earnings Per Share: -33.87 USD

P/E Ratio: -0.12

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 135600

Market Capitalization: 6.2 million

Links: